MIRA PHARMACEUTICALS, INC.

Highlights MIRA Pharmaceuticals, Inc.

Equities

MIRA

US60458C1045

Market Closed - Nasdaq Other stock markets 21:00:00 20/06/2024 BST			5-day change	1st Jan Change
0.732 ^USD	+3.10%		-1.08%	-30.29%

06-10	MIRA Pharmaceuticals, Inc. Announces Positive Preclinical Study Results for Its Novel Oral Ketamine Analog, Ketamir-2, Paving the Way for IND Submission Later This Year	CI
05-29	Sector Update: Health Care Stocks Fall Late Afternoon	MT

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

MIRA Pharmaceuticals, Inc. Announces Positive Preclinical Study Results for Its Novel Oral Ketamine Analog, Ketamir-2, Paving the Way for IND Submission Later This Year	06-10	CI
Sector Update: Health Care Stocks Fall Late Afternoon	05-29	MT
Sector Update: Health Care Stocks Retreat Wednesday Afternoon	05-29	MT
Mira Pharmaceuticals Says US DEA Finds Marijuana Analog a Non-Controlled Substance	05-29	MT
MIRA Pharmaceuticals, Inc. Announces DEA Rules Mira-55, A Novel Oral Pharmaceutical Marijuana Analog, Is Not Classified as A Controlled Substance	05-29	CI
Mira Pharmaceuticals Advances Preclinical Trials Towards an IND Submission This Year for Ketamir-2, A Differentiated Oral Ketamine Analog	05-20	CI
MIRA Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-13	CI
Mira Pharmaceuticals, Inc. Announces Encouraging Preclinical Results Advancing Ketamir-2 Towards Potential Year-End IND Submission	04-02	CI
MIRA Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	04-01	CI
MIRA Pharmaceuticals, Inc. Provides Updated Information Regarding the Patented, Pre-Clinical Drug Candidate Molecule Known as Mira1a	03-07	CI
MIRA Pharmaceuticals, Inc. Releases Breakthrough Data from Artificial Intelligence Simulations	12-04	CI
Mira Pharmaceuticals Signs Licensing Deal for Ketamine Analog Ketamir-2	11-20	MT
MIRA Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-13	CI
MIRA Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	15/09/23	CI
MIRA Pharmaceuticals Closes $8.9 Million IPO	08/08/23	MT
MIRA Pharmaceuticals, Inc. has completed an IPO in the amount of $8.925 million.	02/08/23	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Our Free Content Help you Secure and Increase the Performance of Your Investments

Securing my Investments

fermer